Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
10.1016/j.pbb.2017.07.014 Pharmacol Biochem Behav
The peptide prompts rapid activation of collateral vascular pathways, particularly the azygos vein system, enabling direct blood flow delivery that bypasses occluded vessels
Composition GHK-Cu: 50 mg KPV: 10 mg BPC-157: 10 mg TB-500 (Thymosin Beta 4): 10 mg Appearance: lyophilized powder in a sealed research vial Research Focus (non-clinical) Combined evaluation of copper peptide, KPV tripeptide, BPC-157, and TB-500 in in-vitro or ex-vivo assay systems Assay development, including chromatographic separation of four co-formulated peptides Stability characterization of a four-analyte lyophilized blend under laboratory storage conditions Method documentation for HPLC/LC-MS identity and purity assessments Documentation Lot-specific COA available Batch and lot traceability Important Notice For research use only Not for human consumption Not intended to diagnose, treat, cure, or prevent any disease Quality & Manufacturing Lot-specific COA Lyophilized for transit stability
Schedule an appointment with an experienced plastic surgeon who can administer the glutathione injection safely and effectively
If it's your first time, don't worry
PMID: 21548866 Tkalcevic VI, et al
US$ 21.74
US$ 25.71
US$ 20.00
US$ 20.43
US$ 24.28
US$ 29.76
US$ 23.61
US$ 26.37
US$ 24.75
